Literature DB >> 10702271

Interleukin (IL)-7 induces rapid activation of Pyk2, which is bound to Janus kinase 1 and IL-7Ralpha.

N Benbernou1, K Muegge, S K Durum.   

Abstract

Interleukin-7 (IL-7) receptor signaling begins with activation of the Janus tyrosine kinases Jak1 and Jak3, which are associated with the receptor complex. To identify potential targets of these kinases, we examined Pyk2 (a member of the focal adhesion kinase family) using an IL-7-dependent murine thymocyte line, D1. We demonstrate that stimulation of D1 (or normal pro-T) cells by IL-7 rapidly increased tyrosine phosphorylation and enzymatic activity of Pyk2, with kinetics slightly lagging that of Jak1 and Jak3 phosphorylation. Conversely, IL-7 withdrawal resulted in a marked decrease of Pyk2 phosphorylation. Pyk2 was found to be physically associated with Jak1 prior to IL-7 stimulation and to increase its association with IL-7Ralpha chain following IL-7 stimulation. Pyk2 appeared to be involved in cell survival, because antisense Pyk2 accelerated the cell death process. Activation of Pyk2 via the muscarinic and nicotinic receptors using carbachol or via intracellular Ca(2+) rise using ionomycin/phorbol myristate acetate promoted survival in the absence of IL-7. These data support a role for Pyk2 in coupling Jak signaling to the trophic response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702271     DOI: 10.1074/jbc.275.10.7060

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Differential expression of FAK and Pyk2 in metastatic and non-metastatic EL4 lymphoma cell lines.

Authors:  Zhihong Zhang; Stewart M Knoepp; Hsun Ku; Heather M Sansbury; Yuhuan Xie; Manpreet S Chahal; Stephen Tomlinson; Kathryn E Meier
Journal:  Clin Exp Metastasis       Date:  2011-05-01       Impact factor: 5.150

Review 2.  JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth.

Authors:  Fouad A Zouein; Roy J Duhé; George W Booz
Journal:  Growth Factors       Date:  2011-09-05       Impact factor: 2.511

3.  Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.

Authors:  M B Meads; B Fang; L Mathews; J Gemmer; L Nong; I Rosado-Lopez; T Nguyen; J E Ring; W Matsui; A R MacLeod; J A Pachter; L A Hazlehurst; J M Koomen; K H Shain
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

4.  Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members.

Authors:  Qiong Jiang; Wen Qing Li; Robert R Hofmeister; Howard A Young; David R Hodge; Jonathan R Keller; Annette R Khaled; Scott K Durum
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 5.  Perspectives of the relationship between IL-7 and autoimmune diseases.

Authors:  Xiao-Song Wang; Bao-Zhu Li; Lin-Feng Hu; Peng-Fei Wen; Min Zhang; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2013-08-11       Impact factor: 2.980

6.  Interleukin-7 stimulates secretion of S100A4 by activating the JAK/STAT signaling pathway in human articular chondrocytes.

Authors:  Raghunatha R Yammani; David Long; Richard F Loeser
Journal:  Arthritis Rheum       Date:  2009-03

7.  Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

Authors:  Iwona Bednarz-Misa; Mariusz A Bromke; Małgorzata Krzystek-Korpacka
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13.

Authors:  David Long; Simon Blake; Xiao-Yu Song; Michael Lark; Richard F Loeser
Journal:  Arthritis Res Ther       Date:  2008-02-20       Impact factor: 5.156

Review 9.  Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies.

Authors:  Inge Lodewijckx; Jan Cools
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.